Medicare AdvantageCoverageMedium impact
MA07.052a, Bioimpedance for the Detection of Lymphedema
Independence Blue Cross·Oncology, PM&R (Physical Medicine & Rehab), Vascular Surgery +2 more·Medical Policy
Effective date
Nov 17, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA07.052a for bioimpedance detection of lymphedema has been updated with changes to coverage position, medical necessity criteria, and medical coding requirements. This affects billing and reimbursement for bioimpedance testing used to diagnose lymphedema.
Action Required
By November 17, 2025: Billing team must review updated MA07.052a policy for bioimpedance lymphedema detection to understand new coverage criteria, medical necessity requirements, and coding changes. Update billing workflows and staff training for Medicare Advantage claims involving bioimpedance testing for lymphedema diagnosis.